| MOLOGEN HDS NPV : MOLOGEN AG First evaluation data on clinical trial with ... - 4-traders (press release) |
|
|
4-traders (press release) Berlin, 29 August 2011 – Today, MOLOGEN AG published the first results from the phase I/II clinical trial with the cell-based renal cancer therapy MGN1601. The primary goal of this study is the investigation of safety and tolerability of the medicament |